Zimmer Biomet Holdings Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones

2025.11.24 22:10

I'm PortAI, I can summarize articles.

Zimmer Biomet Holdings Inc. stock rose 1.45% to $93.52 on Monday, marking its second consecutive day of gains. Despite the favorable market session, the stock remains 18.28% below its 52-week high of $114.44. Trading volume was 2.7 million, surpassing the 50-day average of 1.8 million. Competitors like Johnson & Johnson, Medtronic PLC, and Stryker Corp. also saw gains.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Zimmer Biomet Holdings Inc. (ZBH) advanced 1.45% to $93.52 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.55% to 6,705.12 and the Dow Jones Industrial Average rising 0.44% to 46,448.27. This was the stock's second consecutive day of gains. Zimmer Biomet Holdings Inc. closed 18.28% short of its 52-week high of $114.44, which the company reached on April 3rd. The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) rose 1.05% to $206.05, Medtronic PLC (MDT) rose 1.98% to $103.20, and Stryker Corp. (SYK) rose 0.53% to $370.22. Trading volume (2.7 M) eclipsed its 50-day average volume of 1.8 M. Data source: Dow Jones Market Data, FactSet. Data compiled November 24, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-24-25 1710ET